The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trialKiyotaka Uchiyama, Yoshitaka Ishibashi, Chigusa Kitayama et al.|Scientific Reports|2021Cited by 27
Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving TolvaptanKiyotaka Uchiyama, Kaori Hayashi, Daisuke Kamano et al.|Kidney International Reports|2025Cited by 16
Uremic encephalopathy in patients undergoing assisted peritoneal dialysis: a case series and literature reviewAkane Yanai, Yoshitaka Ishibashi, Kiyotaka Uchiyama|CEN Case Reports|2019Cited by 12
Baseline and Time‐Averaged Values Predicting Residual Renal Function Decline Rate in Japanese Peritoneal Dialysis PatientsKiyotaka Uchiyama, Yoshitaka Ishibashi, Mai Yanagi et al.|Therapeutic Apheresis and Dialysis|2017Cited by 11
Sarcomatoid renal cell carcinoma with autosomal dominant polycystic kidney disease: a case report and literature reviewYuji Hakozaki, Yoshitaka Ishibashi, Kiyotaka Uchiyama et al.|CEN Case Reports|2020Cited by 9